loadpatents
name:-0.030102014541626
name:-0.02457594871521
name:-0.0063369274139404
Terman; David S Patent Filings

Terman; David S

Patent Applications and Registrations

Patent applications and USPTO patent grants for Terman; David S.The latest application filed is for "compositions and methods for treatment of cancer".

Company Profile
8.24.29
  • Terman; David S - Pebble Beach CA US
  • Terman; David S. - Pebble Beach CA US
  • Terman; David S. - Houston TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions and methods for treatment of cancer
Grant 10,952,975 - Terman March 23, 2
2021-03-23
Compositions and Methods for Treatment of Cancer
App 20210069314 - Terman; David S. ;   et al.
2021-03-11
Compositions and Methods for Treatment of Cancer
App 20200297658 - Terman; David S
2020-09-24
Compositions and methods for treatment of cancer
Grant 10,314,903 - Terman , et al.
2019-06-11
Compositions and Methods for Treatment of Cancer
App 20180028639 - Terman; David S. ;   et al.
2018-02-01
Sickled Erythrocytes and Progenitors Target Cytotoxics to Tumors
App 20160144002 - Terman; David S.
2016-05-26
Tumor Targeted Sickle Erythroid Precursors, Progenitors and Hematopoietic Stem Cells, Induced Pluripotent Stem Cells, Microparticles and Liposomes for Treatment of Cancer
App 20160058793 - Terman; David S.
2016-03-03
Sickled Erythrocytes and Progenitors Target Cytotoxics to Tumors
App 20150037297 - Terman; David S
2015-02-05
Compositions and Methods for Treatment of Neoplastic Disease
App 20140205617 - Terman; David S.
2014-07-24
Composition and Methods for Treatment of Cancer
App 20140088020 - Terman; David S
2014-03-27
Compositions and methods for treatment of neoplastic disease
Grant 8,524,218 - Terman September 3, 2
2013-09-03
Knowledge acquisition nexus for facilitating concept capture and promoting time on task
Grant 8,488,916 - Terman July 16, 2
2013-07-16
Sickled erythrocytes with anti-tumor agents induce tumor vaso-occlusion and tumoricidal effects
Grant 8,431,117 - Terman April 30, 2
2013-04-30
Knowledge Acquisition Mulitplex Facilitates Concept Capture and Promotes Time on Task
App 20130021346 - Terman; David S.
2013-01-24
Sickled Erythrocytes with Anti-tumor Agents Induce Tumor Vaso-occlusion and Tumoricidal Effects
App 20120195869 - Terman; David S.
2012-08-02
Compositions and methods for treatment of cancer
App 20120148628 - Terman; David S.
2012-06-14
Intrathecal and intratumoral superantigens to treat malignant disease
Grant 8,128,931 - Terman March 6, 2
2012-03-06
Compositions and Methods for Treatment of Neoplastic Disease
App 20110059901 - Terman; David S.
2011-03-10
Compositions and methods for treatment of neoplastic disease
Grant 7,803,637 - Terman September 28, 2
2010-09-28
Intrathecal and intratumoral superantigens to treat malignant disease
Grant 7,776,822 - Terman August 17, 2
2010-08-17
Sickled Erythrocytes, Nucleated Precursors & Erythroleukemia Cells for Targeted Delivery of Oncolytic Viruses, Anti-tumor Proteins, Plasmids, Toxins, Hemolysins & Chemotherapy
App 20100203024 - Terman; David S. ;   et al.
2010-08-12
Intrathecal and Intratumoral Superantigens to Treat Malignant Disease
App 20100196373 - Terman; David S.
2010-08-05
Enterotoxin gene cluster (egc) superantigens to treat malignant disease
App 20090162315 - Terman; David S. ;   et al.
2009-06-25
Compositions and methods for treatment of neoplastic disease
App 20050112141 - Terman, David S.
2005-05-26
Compositions and methods for treatment of neoplastic disease
App 20040214783 - Terman, David S.
2004-10-28
Tumor killing effects of enterotoxins, superantigens, and related compounds
Grant 6,692,746 - Terman , et al. February 17, 2
2004-02-17
Compositions and methods for treatment of neoplastic disease
App 20030157113 - Terman, David S.
2003-08-21
Compositions and methods for treatment of neoplastic disease
App 20020177551 - Terman, David S.
2002-11-28
Polymerized staphylococcal protein a for treatment of diseases
Grant 6,447,777 - Terman , et al. September 10, 2
2002-09-10
Method of cancer treatment
App 20020051765 - Terman, David S.
2002-05-02
Tumor killing effects of enterotoxins, superantigens, and related compounds
Grant 6,338,845 - Terman January 15, 2
2002-01-15
Method of cancer treatment
Grant 6,251,385 - Terman June 26, 2
2001-06-26
Tumor killing effects of enterotoxins, superantigens, and related compounds
Grant 6,221,351 - Terman April 24, 2
2001-04-24
Method of cancer treatment
Grant 6,180,097 - Terman January 30, 2
2001-01-30
Tumor killing effects of enterotoxins, superantigens, and related compounds
Grant 6,126,945 - Terman , et al. October 3, 2
2000-10-03
Method of cancer treatment
Grant 5,728,388 - Terman March 17, 1
1998-03-17
Protein A perfusion and post perfusion drug infusion
Grant 5,091,091 - Terman February 25, 1
1992-02-25
Variable volume plasma treatment chamber for an apparatus for the extracorporeal treatment of disease
Grant 4,223,672 - Terman , et al. September 23, 1
1980-09-23
Apparatus for the extracorporeal treatment of disease
Grant 4,215,688 - Terman , et al. August 5, 1
1980-08-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed